Metabolites from Lactococcus lactis subsp. lactis: Isolation, Structure Elucidation, and Antimicrobial Activity

Area of Science:

• Microbiology
• Natural Product Chemistry
• Drug Discovery

Background:

• Probiotic microorganisms are a source of bioactive compounds.
• Lactococcus lactis subsp. lactis is a dairy-derived bacterium with potential health benefits.
• Traditional dairy products can harbor unique microbial strains.

Purpose of the Study:

• To identify and characterize novel metabolites from Lactococcus lactis subsp. lactis.
• To evaluate the antimicrobial potential of isolated metabolites.
• To explore new therapeutic agents from natural sources.

Main Methods:

• Isolation and purification of metabolites using chromatography.
• Structure elucidation via NMR spectroscopy (1D and 2D) and mass spectrometry.
• Antimicrobial activity testing using minimum inhibitory concentration (MIC) assays.

Main Results:

• Four novel metabolites were identified: pyrazinamide (1), DDMP (2), 2,4-di-tert-butylphenol (3), and palmitic acid (4).
• The chemical structures were confirmed by NMR, mass spectrometry, and X-ray crystallography.
• Compounds 1 and 3 demonstrated potent broad-spectrum antimicrobial activity with MICs between 1.56-25 μg/mL.

Conclusions:

• Lactococcus lactis subsp. lactis produces bioactive metabolites with significant antimicrobial properties.
• Pyrazinamide and 2,4-di-tert-butylphenol show promise as leads for developing new antimicrobial agents.
• This study highlights the potential of dairy-derived probiotics as a source of novel therapeutic compounds.